Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia

  1. Gómez García, L.M.
  2. Escudero, A.
  3. Mestre, C.
  4. Fuster Soler, J.L.
  5. Martínez, A.P.
  6. Vagace Valero, J.M.
  7. Vela, M.
  8. Ruz, B.
  9. Navarro, A.
  10. Fernández, L.
  11. Fernández, A.
  12. Leivas, A.
  13. Martínez-López, J.
  14. Ferreras, C.
  15. De Paz, R.
  16. Blanquer, M.
  17. Galán, V.
  18. González, B.
  19. Corral, D.
  20. Sisinni, L.
  21. Mirones, I.
  22. Balas, A.
  23. Vicario, J.L.
  24. Valle, P.
  25. Borobia, A.M.
  26. Pérez-Martínez, A.
  27. Erakutsi egile guztiak +
Aldizkaria:
Clinical Lymphoma, Myeloma and Leukemia

ISSN: 2152-2669 2152-2650

Argitalpen urtea: 2021

Alea: 21

Zenbakia: 5

Orrialdeak: 328-337.e1

Mota: Artikulua

DOI: 10.1016/J.CLML.2021.01.013 GOOGLE SCHOLAR